News Focus
News Focus
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

Re: Bickema post# 15715

Friday, 08/05/2016 11:16:55 AM

Friday, August 05, 2016 11:16:55 AM

Post# of 20689
Necuparanib R&D expense was $0.7M during 2Q16, according to MNTA's PR (#msg-124305312).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”